Showing 3 of 3 posts
June 2, 2021 | Blogs
The recently introduced Medical Fund Bill has potential to improve access to novel therapies applying for reimbursement in Poland, however, it is yet to be seen how the criteria for inclusion in the Fund’s list are clarified locally and whether a broader scope of therapies will be eligible for the scheme to deem the market more attractive for submissions.
July 10, 2019 | Blogs, Infographics
The Impact of Central and Eastern European (CEE) International Reference Pricing (IRP) Policy Changes
Changes to IRP policies in the CEE markets can impact pricing across the EU region and should therefore be closely monitored particularly as the list price in a given CEE market may be re-referenced by other global markets.
October 4, 2017 | Blogs
Rome Wasn’t Built in a Day Either: Greece is Back Again with New Pricing and Reimbursement Policy Reforms
CBPartners explores the new pricing and reimbursement policy reforms in Greece.